Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine effects on brain structure and function in Alzheimer's disease
2005-005859-18Phase 3Active
- Sponsor
- Fondazione Santa Lucia IRCCS
- Start
- Nov 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of memantine in Alzheimer's disease (AD) (2 arms), sponsored by Fondazione Santa Lucia IRCCS. Primary endpoint: Cognitive performance improvement. Started Nov 2006; status: active.
02
Drugs
memantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on 2005-005859-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005859-18.